PDE4A and atopic eczema: Interestingly, as a PDE4 inhibitor, small-molecule drug apremilast was applied in the treatment of atopic dermatitis, which, like scleroderma, belongs to type 2 inflammatory diseases (Abrouk et al., 2017).